Targeting the Function of the HER2 Oncogene in Human Cancer Therapeutics

Oncogene - United Kingdom
doi 10.1038/sj.onc.1210478
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HER2/neu Antisense Therapeutics in Human Breast Cancer

2002English

Construction and Characterization of Novel, Completely Human Serine Protease Therapeutics Targeting Her2/Neu

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Targeting Microenvironment in Cancer Therapeutics

Oncotarget
Oncology
2016English

Targeting HER2+ Breast Cancer: The TBK1/IKK-Epsilon Axis

Oncoscience
Cancer ResearchOncology
2014English

Targeting Checkpoint Kinase 1 in Cancer Therapeutics

Clinical Cancer Research
Cancer ResearchOncology
2007English

Perspectives of HER2-targeting in Gastric and Esophageal Cancer

Expert Opinion on Investigational Drugs
MedicinePharmacology
2017English

Therapeutics Targeting the Fibrinolytic System

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2020English

Targeting Tumor Suppressor Networks for Cancer Therapeutics

Current Drug Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2014English

Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

International Journal of Cell Biology
Cell Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy